Experimental tissue mimicking human head phantom for estimation of stroke using IC-CF-DMAS algorithm in microwave based imaging system.
Mohammad Shahidul Islam, Mohammad Tariqul Islam, Ali F Almutairi
https://pubmed.ncbi.nlm.nih.gov/34759284/Actively Recruiting
Led by B&B srl · Updated on 2026-09-24
850
Participants Needed
3
Research Sites
4 weeks
Total Duration
Researchers are evaluating the TES HT100 device as a non-invasive tool to identify intracranial abnormalities in adult emergency department patients who have mild head trauma or neurological symptoms unrelated to trauma that are not immediately life-threatening. This study aims to compare the accuracy and safety of the TES HT100 device with head CT scans, the current standard for detecting brain injuries. It also explores whether TES HT100 could support better patient triage and resource use in emergency settings. Participants will receive usual emergency care, including a head CT scan, and undergo an additional TES HT100 examination lasting about 5 minutes. The TES HT100 uses ultra-low-power, non-ionizing electromagnetic waves to detect brain abnormalities and provides a simple yesno result. The device examination is performed by trained staff and is done within 24 hours before or after the CT scan. The study plans to enroll approximately 850 adults across three centers in Italy and Poland over 30 months. During the study, participants will have their TES HT100 results compared to their CT reports to assess diagnostic accuracy. Safety monitoring will track any adverse events related to the TES HT100 device throughout the participation, which lasts about one year on average. Researchers will also collect information on the time, procedures, and costs related to TES HT100 use. The overall goal is to gather evidence on TES HT100s performance and safety as a rapid screening tool in emergency care.
CONDITIONS
TES HT100 Clinical Validation for Brain Injury Screening in Patients With Mild Head Trauma or Neurological Symptoms
F
Fabrizio Alfieri
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
B&B srl
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Within 24 hours
Participants receive standard emergency evaluation including head CT and an additional TES HT100 examination lasting about 5 minutes.
1 visit (in-person)
Duration - Approximately 1 year
Researchers monitor participants for any device-related adverse events and collect safety and diagnostic data over about one year.
Regular safety monitoring visits
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Mohammad Shahidul Islam, Mohammad Tariqul Islam, Ali F Almutairi
https://pubmed.ncbi.nlm.nih.gov/34759284/Sara Montemerani, Cosimo Fabrizi, Cecilia Sacchi...
https://pubmed.ncbi.nlm.nih.gov/39659448/C Gabriel, S Gabriel, E Corthout
https://pubmed.ncbi.nlm.nih.gov/8938024/Ann C Mckee, Daniel H Daneshvar
https://pubmed.ncbi.nlm.nih.gov/25702209/C Lefevre-Dognin, M Cogné, V Perdrieau...
https://pubmed.ncbi.nlm.nih.gov/32387427/Alexandra Brazinova, Veronika Rehorcikova, Mark S Taylor...
https://pubmed.ncbi.nlm.nih.gov/26537996/Adriana Modestina Conte, Fabrizio Alfieri, Angelo Localzo...
https://pubmed.ncbi.nlm.nih.gov/42414903/S Gabriel, R W Lau, C Gabriel
https://pubmed.ncbi.nlm.nih.gov/8938025/B&B srl
Lead Sponsor